Exponent delivered results ahead of Wall Street expectations in Q4, with management crediting growth in both proactive and ...

Exponent (EXPO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future ...

MENLO PARK, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the fourth quarter and fiscal year 2025 ended January 2, 2026.

Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday after market hours. Here’s what ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 12.3% in the afternoon session after the company reported fourth-quarter 2025 financial results that beat analyst estimates and ...

MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (EXPO) today reported financial results for the third quarter of fiscal year 2025 ended October 3, 2025. “Exponent delivered a ...